Solid Biosciences Inc. (SLDB)

Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	75.85	157.22	121.21	155.07	76.37
Short-Term Investments	49.63	58.34	88.64	0	7.48
Cash & Cash Equivalents	125.47	215.56	209.85	155.07	83.85
Cash Growth	-41.79%	2.72%	35.32%	84.94%	-31.71%
Receivables	0	0	0.11	0	0
Other Current Assets	4.26	4.08	12.65	3.83	2.45
Total Current Assets	129.73	219.64	222.61	158.9	86.3
Property, Plant & Equipment	33.16	38.61	7.6	11.73	16.63
Other Long-Term Assets	2.04	2.01	2.16	0.54	0.54
Total Long-Term Assets	35.21	40.61	9.77	12.27	17.17
Total Assets	164.94	260.25	232.38	171.17	103.47
Accounts Payable	2.03	3.24	4.46	3.27	7.12
Deferred Revenue	0	0	8.08	20.72	0
Current Debt	2.32	2.57	1.5	2.21	1.92
Other Current Liabilities	10.16	16.71	9.56	-1.72	9.23
Total Current Liabilities	14.52	22.51	23.6	24.48	18.28
Long-Term Debt	23.94	25.98	0.57	2.94	5.15
Other Long-Term Liabilities	0	0.1	0	11.66	0
Total Long-Term Liabilities	23.94	26.08	0.57	14.6	5.15
Total Liabilities	38.46	48.59	24.17	39.08	23.42
Total Debt	26.27	28.55	2.06	5.15	7.07
Debt Growth	-7.99%	1283.76%	-59.95%	-27.13%	584.98%
Retained Earnings	-658.75	-562.74	-476.76	-404.57	-316.28
Comprehensive Income	0.02	-0.07	-0.05	0	0
Shareholders' Equity	126.48	211.67	208.21	132.09	80.05
Net Cash / Debt	99.21	187.01	207.79	149.92	76.78
Net Cash / Debt Growth	-46.95%	-10.00%	38.60%	95.25%	-36.94%
Net Cash Per Share	4.99	21.97	29.19	43.30	28.59
Working Capital	115.22	197.13	199.01	134.42	68.03
Book Value Per Share	6.36	24.87	29.25	38.15	29.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).